Company News

DRUGDOCS<sup>®</sup> Announces an Exciting New Update to Portal

ANNOUNCEMENT

   •   March 4, 2024


DRUGDOCS® Announces an Exciting New Update to Portal


DRUGDOCS® is pleased to introduce a new look. The new portal makes it even easier for healthcare professionals to get the latest drug information they need to make informed, evidence-based decisions.


Read Now
Thera-Business Promotes Sheldon Yu to Senior Research Analyst

ANNOUNCEMENT

   •   January 17, 2024

Thera-Business Promotes Sheldon Yu to Senior Research Analyst

We are thrilled to announce the promotion of Mr. Sheldon Yu to the position of Senior Research Analyst at Thera-Business Consulting. Mr Yu’s appointment to this new role highlights his statistical and analytical expertise, his valued role on our team, and his dedication to Thera-Business, having been with us since 2019.

Read Now
Thera-Business Promotes Rami Ali to Project Manager

ANNOUNCEMENT

   •   January 9, 2024

Thera-Business Promotes Rami Ali to Project Manager

It is with great pleasure that we announce the promotion of Mr. Rami Ali to the role of Project Manager at Thera-Business. The appointment to this new position is an indication of Mr. Ali’s exceptional dedication, expertise, and commitment, as well as his invaluable role on our team.

Read Now
Thera-Business Promotes Lindsay Kemp to Director of Operations

ANNOUNCEMENT

   •   January 4, 2024

Thera-Business Promotes Lindsay Kemp to Director of Operations

We are pleased to announce Lindsay Kemp’s promotion into the role of Director of Operations. With over 15 years of invaluable and varied experience in the health science sector, Lindsay is well-equipped to lead the operations of Thera-Business.

Read Now
Thera-Business Welcomes Diana Kao as Senior Health Research Analyst

ANNOUNCEMENT

   •   November 7, 2023

Thera-Business Welcomes Diana Kao as Senior Health Research Analyst

Thera-Business is excited to announce that Ms. Diana Kao, B.Sc., M.Sc., has joined our team as a Senior Health Research Analyst. Ms. Kao received her M.Sc. in Epidemiology from the London School of Hygiene & Tropical Medicine after completing her BSc in Biology at the University of British Columbia. Ms. Kao has 15 years of research experience in both quantitative and qualitative public health/epidemiological studies on infectious and chronic diseases.

Read Now
American Medical Women’s Association and DrugDocs Inc. Partner To Raise Sex/Gender Awareness in Disease Treatment

PRESS RELEASE

   •   November 2, 2023

American Medical Women’s Association and DrugDocs Inc. Partner To Raise Sex/Gender Awareness in Disease Treatment

A sister company to Thera-Business, DrugDocs Inc. shares exciting information today about an exciting strategic partnership with the American Medical Women’s Association to raise sex/gender awareness in disease treatment.

Read Now
Battle-Tested Strategies for Evidence Synthesis

WEBINAR

   •   November 1, 2023

Battle-Tested Strategies for Evidence Synthesis

Dr. Isabella Steffensen and Dr. Mimi Kim are delighted to be presenting on the topic of Battle-Tested Strategies for Evidence Synthesis with our partners at Rayyan Systems. Please join us on November 2, 2023, from 12pm to 1pm EST, for this free, interactive webinar.

Read Now
Rayyan and Thera-Business Partner to Elevate Regulatory Compliant Evidence Synthesis

PRESS RELEASE

   •   September 29, 2023

Rayyan and Thera-Business Partner to Elevate Regulatory Compliant Evidence Synthesis

Rayyan Systems, Inc. and Thera-Business Inc. proudly announce a strategic partnership to deliver unparalleled evidence synthesis solutions for research organizations and regulated biomedical and healthcare entities.

Read Now
Preserving Methodology in an Era of Rapid Innovation

INSIGHT

   •   September 21, 2023

Preserving Methodology in an Era of Rapid Innovation

I will never forget the words of a mentor who offered me a piece of sage advice that’s reflexively become my go-to when I face a challenge today. I ask myself this one basic question: What are we trying to solve for?

Read Now
Understanding the Fixed-Effect Assumption in Meta-Analysis: A No-Nonsense Explanation

INSIGHT

   •   August 15, 2023

Understanding the Fixed-Effect Assumption in Meta-Analysis: A No-Nonsense Explanation

Imagine you're at the FIFA Women’s World Cup finals and you learn that the average IQ of everyone in the stadium is 102. Now, let's say you decide to estimate this average IQ for yourself. You randomly select 15 batches of 500 people from the stadium ...

Read Now
Raising the Bar of Transparency and Replicability for the Gold Standard of Methodology

INSIGHT

   •   August 1, 2023

Raising the Bar of Transparency and Replicability for the Gold Standard of Methodology

"I had considerable freedom of clinical choice of therapy: My trouble was that I did not know which to use and when. I would gladly have sacrificed my freedom for a little knowledge." (Cochrane, A.L., 1971)

Read Now
Thera-Business Promotes Vlad Kuznetsov as Director of Software Development

ANNOUNCEMENT

   •   July 1, 2023

Thera-Business Promotes Vlad Kuznetsov as Director of Software Development

Thera-Business would like to congratulate Vlad Kuznetsov on his promotion to Director of Software Development. Here at Thera-Business we know that he will continue to excel in this new role. Mr. Kuznetsov been with Thera-Business since 2020. He has held the roles of Programmer & Data Analyst and Senior Programmer & Data Analyst.

Read Now
Thera-Business Welcomes Isabelle Fakhoury to the Medical Writing Team

ANNOUNCEMENT

   •   June 1, 2023

Thera-Business Welcomes Isabelle Fakhoury to the Medical Writing Team

Thera-Business is pleased to welcome Dr. Isabelle Fakhoury to the team as a Senior Medical Writer. Isabelle joins us with an MSc in Genetics from Paris 7 University, France, and a PhD in Cell and Molecular Biology from the American University of Beirut, Lebanon. She completed her postdoctoral training at ...

Read Now
We've completed 500+ projects for leading medical device and pharmaceutical companies, as well as government health agencies.